blogs.harvard.edu

Share

blogs.harvard.edu

 •  November 15, 2017

Summary: The number of patients enrolled in the trials used to support the registration of novel orphan product are significantly smaller that non-orphan products. One measure of this is the difference in the enrollment of trials cited in the FDA drug trials snapshots. Since 2015, the average number of trials cited in the FDA trials snapshots for...

blogs.harvard.edu

 •  September 21, 2017

If you are fortunate enough to have an insurance plan with extensive coverage and low co-pays for prescription drugs, chances are you may not be overly concerned with the U.S. drug price catastrophe. For millions of Americans without such a plan, getting the much-needed prescribed medicine often involves frustrating multi-player exchanges between...

blogs.harvard.edu

 •  March 31, 2017

Yesterday, a group of 20 Democrats in both the House and Senate introduced the Improving Access to Affordable Prescription Drugs Act, a 129-page bill designed to lower drug costs while increasing innovation and promoting transparency. The bill aims to accomplish a number of different goals, and in this post I’ll go through the different functions...